Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 30.e1-30.e7

  Trautmann, Gail M ^a   Kip, Kevin E ^a   Richter, Holly E ^b   Soper, David E ^c   Peipert, Jeffrey F ^d   Nelson, Deborah B ^e   Trout, Wayne ^f   Schubeck, Dianne ^g   Bass, Debra C ^a   Ness, Roberta B ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g METROHEALTH MEDICAL CENTER   (United States)

Author keywords

adnexitis; chlamydia; chronic pain; endometritis; infertility; prediction; recurrent pelvic inflammatory disease; treatment

Indexed keywords

CEFOXITIN; DOXYCYCLINE; PROBENECID;

ADOLESCENT; ADULT; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME; UTERINE CERVICITIS;

EID: 37349086110     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.05.021     Document Type: Article

References (39)

1. Sutton M.Y., Sternberg M., Zaidi A., St Louis M.E., and Markowitz L.E. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 32 (2005) 778-784
2. Westrom L., Joesoef R., Reynolds G., Hagdu A., and Thompson S.E. Pelvic inflammatory disease and fertility: a cohort of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19 (1992) 185-192
3. Simms I., and Stephenson J.M. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?. Sex Transm Inf 76 (2000) 80-87
4. Haggerty C.L., Shulz R., and Ness R.B. Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet Gynecol 102 (2003) 934-939
5. Brunham R.C., Binns B., Guijon F., et al. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 158 (1998) 510-517
6. Rein D.B., Kassler W.J., Irwin K.L., and Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol 95 (2000) 397-402
7. Peipert J.F., Sweet R.L., Walker C.K., Kahn J., and Rielly-Gauvin K. Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis). Infect Dis Obstet Gynecol 7 (1999) 138-144
8. Wendel Jr. G.D., Cox S.M., Bawdon R.E., Theriot S.K., Heard M.C., and Nobles B.J. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. Am J Obstet Gynecol 164 (1991) 1390-1396
9. Malhotra M., Sharma J.B., Batra S., Arora R., and Sharma S. Ciprofloxacin-tinidazole combination, fluconazole-azithromicin-secnidazole-kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. Indian J Med Sci 57 (2003) 549-555
10. Thadepalli H., Mathai D., Scotti R., Bansal M.D., and Savage E. Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin. Obstet Gynecol 78 (1991) 696-702
11. Wolner-Hanssen P., Paavonen J., Kiviat N., Young M., Eschenbach D.A., and Holmes K.K. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Obstet Gynecol 71 (1988) 595-600
12. Hemsell D.L., Little B.B., Faro S., et al. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clin Infect Dis 19 (1994) 720-727
13. Arredondo J.L., Diaz V., Gaitan H., et al. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. Clin Infect Dis 24 (1997) 170-178
14. Soper D.E., Brockwell N.J., and Dalton H.P. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol 167 (1992) 653-660
15. Walker C.K., Kahn J.G., Washington A.E., Peterson H.B., and Sweet R.L. Pelvic inflammatory disease: a metaanalysis of antimicrobial regimen efficacy. J Inf Dis 168 (1993) 969-978
16. Bruhat M.A., LeBouedec G., Pouly J.L., Mage G., and Canis M. Treatment of acute salpingitis with sulbactam/ampicillin. Suppl Int J Gynecol Obstet 2 suppl (1989) 41-46 discussion 47-8
17. Brunham R.C., MacLean I.W., Binns B., and Peeling R.W. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 152 (1985) 1275-1282
18. Teisala K., Heinonen P.K., Aine R., Punnonen R., and Paavonen J. Second laparoscopy after treatment of acute pelvic inflammatory disease. Obstet Gynecol 69 Pt. 1 (1987) 343-346
19. Kosseim M., Ronald A., Plummer F.A., D'Costa L., and Brunham R.C. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam. Antimicrob Agents Chemother 35 (1991) 1651-1656
20. Tomioka E.S., Anzai R.Y., Kwang W.N., et al. Endometrial damage in acute salpingitis. Sex Trans Dis 14 (1987) 63-68
21. Yeh J.M., Hook III E.W., and Goldie S.J. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 30 (2003) 369-378
22. Ness R.B., Soper D.E., Holley R.L., et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 186 (2002) 929-937
23. Ness R.B., Soper D.E., Peipert J., et al. Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials 19 (1998) 499-514
24. McCormack W.M., Nowroozi K., Alpert S., et al. Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrocholoride. Sex Transm Dis 4 (1977) 125-131
25. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 (1991) 297-301
26. Ness R.B., Keder L.M., Soper D.E., et al. Oral contraception and the recognition of endometritis. Am J Obstet Gynecol 176 (1997) 580-585
27. Kiviat N.B., Wolner-Hanssen P., Eschenbach D.A., et al. Endometrial histopathy in patients with culture proven upper gential tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 14 (1990) 167-175
28. Von Korff M., Ormel J., Keefe F.J., and Dworkin S.F. Grading the severity of chronic pain. Pain 50 (1992) 133-149
29. Sweet R.L., Schachter J., and Robbie M.O. Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 250 (1983) 2641-2645
30. Hillis S.D., Joesoef R., Marchbanks P.A., Wasserheit J.N., Cates Jr. W., and Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 168 (1993) 1503-1509
31. Patton D.L., and Kuo C.C. Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J Reprod Fertil 85 (1989) 647-656
32. Patton D.L., Kuo C.C., and Wang SP Halbert S.A. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis 155 (1987) 1292-1299
33. Van Voorhis W.C., Barrett L.K., Sweeney Y.T., Kuo C.C., and Patton D.L. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun 65 (1997) 2175-2182
34. Soper D.E., Brockwell N.J., Dalton H.P., and Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 170 (1994) 1008-1017 discussion 1014-7
35. Simms I., Eastick K., Mallinson H., et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. J Clin Pathol 56 (2003) 616-618
36. Cohen C.R., Manhart L.E., Bukusi E.A., et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 359 (2002) 765-766
37. Ullmann U., Schubert S., and Krausse R. Comparative in-vitro activity of levofloxacin, other fluroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J Antimicrob Chemother 43 Suppl C (1999) 33-36
38. Haggerty C.L., Ness R.B., Amortegui A., et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol 188 (2003) 141-148
39. In: Holmes K.K., Sparling P.F., and Mardh P. (Eds). Sexually transmitted diseases: pelvic inflammatory disease (1999), McGraw Hill, New York